Lack of Attenuation of a Candidate Dengue 1 Vaccine (45AZ5) in Human Volunteers

K. T. McKee Jr.U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21701-5011

Search for other papers by K. T. McKee Jr. in
Current site
Google Scholar
PubMed
Close
,
W. H. BancroftWalter Reed Army Institute of Research, Washington, DC 20307

Search for other papers by W. H. Bancroft in
Current site
Google Scholar
PubMed
Close
,
K. H. EckelsWalter Reed Army Institute of Research, Washington, DC 20307

Search for other papers by K. H. Eckels in
Current site
Google Scholar
PubMed
Close
,
R. R. RedfieldWalter Reed Army Institute of Research, Washington, DC 20307

Search for other papers by R. R. Redfield in
Current site
Google Scholar
PubMed
Close
,
P. L. SummersWalter Reed Army Institute of Research, Washington, DC 20307

Search for other papers by P. L. Summers in
Current site
Google Scholar
PubMed
Close
, and
P. K. RussellWalter Reed Army Institute of Research, Washington, DC 20307

Search for other papers by P. K. Russell in
Current site
Google Scholar
PubMed
Close
Restricted access

A dengue type 1, candidate live virus vaccine (45AZ5) was prepared by serial virus passage in fetal rhesus lung cells. Infected cells were treated with a mutagen, 5-azacytidine, to increase the likelihood of producing attenuated variants. The vaccine strain was selected by cloning virus that produced only small plaques in vitro and showed reduced replication at high temperatures (temperature sensitivity). Although other candidate live dengue virus vaccines selected for similar growth characteristics have been attenuated for humans, two recipients of the 45AZ5 virus developed unmodified acute dengue fever. Viremia was observed within 24 hr of inoculation and lasted 12 to 19 days. Virus isolates from the blood produced large plaques in cell culture and showed diminished temperature sensitivity. The 45AZ5 virus is unacceptable as a vaccine candidate. This experience points out the uncertain relationship between in vitro viral growth characteristics and virulence factors for humans.

Save